333 related articles for article (PubMed ID: 17889198)
1. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
2. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
4. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
[TBL] [Abstract][Full Text] [Related]
6. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
8. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.
Doron S; Ruthazer R; Werner BG; Rabson A; Snydman DR
Transplantation; 2006 Mar; 81(5):697-703. PubMed ID: 16534471
[TBL] [Abstract][Full Text] [Related]
9. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J
Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466
[TBL] [Abstract][Full Text] [Related]
10. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
[TBL] [Abstract][Full Text] [Related]
11. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study.
Yamani MH; Avery R; Mawhorter SD; McNeill A; Cook D; Ratliff NB; Pelegrin D; Colosimo P; Kiefer K; Ludrosky K; Hobbs R; Taylor D; Buda T; Yeager M; Young JB; Smedira N; Starling RC
J Heart Lung Transplant; 2005 Nov; 24(11):1766-9. PubMed ID: 16297779
[TBL] [Abstract][Full Text] [Related]
12. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
[TBL] [Abstract][Full Text] [Related]
14. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
[TBL] [Abstract][Full Text] [Related]
15. Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.
Miller LW; Naftel DC; Bourge RC; Kirklin JK; Brozena SC; Jarcho J; Hobbs RE; Mills RM
J Heart Lung Transplant; 1994; 13(3):381-92; discussion 393. PubMed ID: 8061013
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
17. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
[TBL] [Abstract][Full Text] [Related]
18. The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients.
Ozdemir FN; Akgul A; Altunoglu A; Bilgic A; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):990-2. PubMed ID: 17524871
[TBL] [Abstract][Full Text] [Related]
19. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
